• About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
  • About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
TECHNOLOGY TRANSFER

Innovator Profile

Headshot of Debbie Crans.

Debbie Crans, PhD

Professor, Department of Chemistry

Primary College

  • College of Natural Sciences

Innovator Links

  • LinkedIn
  • PubMed
  • Faculty Profile

Innovator Bio

Dr. Crans is a Professor of Organic, Inorganic and Biological Chemistry and of Cell and Molecular Biology at Colorado State University where she has served as Professor Laureate of the College of Natural Sciences. Her work focuses on technologies with applications in diseases such as cancer, tuberculosis, Alzheimer’s, and diabetes.

Dr. Cran’s research interest is in the fundamental chemistry and biochemistry of drugs with particular interest in vanadium and other transition metal ions as metals in medicine and their mechanisms of toxicity. Her group has successfully synthesized new compounds, characterized them, and tested their biological properties. Work has focused on lipid systems and micro-emulsion environments to help better understand how drugs and metabolites interact and penetrate lipid interfaces. Additional projects have begun to look at the menaquinone metabolism and inhibition of electron transport in tuberculosis bacteria as well as characterization of amyloid interactions with metal ions and their aggregation leading to a better understanding of new and existing drugs.

Innovator Technologies

Novel Vanadium Complexes to Treat Solid Tumors

Cancer treatment

Synthesis and Characterization of Vanadium (IV/V) Citrate Complexes

Innovator Patents

US4701285A: Acyl phosphate salts and their use.

US20220396593A1: Synthesis and characterization of vanadium complexes.

WO2022232944A1: Pharmaceutical compositions comprising vanadium salts.

Patent list generated using Google Patents.

Strata logo white
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
Serving the Colorado State University System with strategic real estate services, intellectual property protection and licensing, and financing activities.
Integrity
Reliability
Respect
Innovation
Excellence
Submit Disclosure

Newsletter Sign Up

Connect